Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman's and Bartter's syndromes

J Intern Med. 2022 Apr;291(4):522-524. doi: 10.1111/joim.13426. Epub 2021 Dec 16.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2 / metabolism*
  • Bartter Syndrome* / genetics
  • COVID-19*
  • Glycosylation
  • Humans

Substances

  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2